Skip to Content
Merck
CN
All Photos(1)

Key Documents

View All Documentation

Safety Information

425745

Sigma-Aldrich

Yttrium(III) trifluoromethanesulfonate

98%

Synonym(s):

Trifluoromethanesulfonic acid yttrium(III) salt, Yttrium triflate

Sign Into View Organizational & Contract Pricing

Select a Size

2 G
¥1,429.29

¥1,429.29

Estimated to ship on2025年9月01日Details

Request a Bulk Order
All Photos(1)

Select a Size

Change View
2 G
¥1,429.29

About This Item

Linear Formula:
(CF3SO3)3Y
CAS Number:
52093-30-8
Molecular Weight:
536.11
MDL number:
MFCD00209623
UNSPSC Code:
12161600
PubChem Substance ID:
24866664
NACRES:
NA.22

¥1,429.29

Estimated to ship on2025年9月01日Details

Request a Bulk Order

Quality Level

100

Assay

98%

reaction suitability

core: yttrium
reagent type: catalyst

SMILES string

[Y+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F

InChI

1S/3CHF3O3S.Y/c3*2-1(3,4)8(5,6)7;/h3*(H,5,6,7);/q;;;+3/p-3

InChI key

JPJIEXKLJOWQQK-UHFFFAOYSA-K

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
615595490865490199
Maleic acid-2,3-13C2 99 atom % 13C

490180

Maleic acid-2,3-13C2

Maleic acid-2,3-d2 98 atom % D

615595

Maleic acid-2,3-d2

Myristic acid-1,2-13C2 99 atom % 13C, 99% (CP)

490865

Myristic acid-1,2-13C2

Malonic acid-1,3-13C2 99 atom % 13C

490199

Malonic acid-1,3-13C2

assay

99% (CP)

assay

-

assay

99% (CP)

assay

-

isotopic purity

99 atom % 13C

isotopic purity

98 atom % D

isotopic purity

99 atom % 13C

isotopic purity

99 atom % 13C

mass shift

M+2

mass shift

M+2

mass shift

M+2

mass shift

M+2

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

form

solid

form

solid

form

solid

form

solid

mp

137-140 °C (lit.)

mp

137-140 °C (lit.)

mp

52-54 °C (lit.)

mp

132-135 °C (dec.) (lit.)

Application

Recently used to promote glycosidation of glycosyl fluorides[1] and as a catalyst in the preparation of pyridine[2] and quinoline[2][3] derivatives.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCT5114
MKCL5428
MKCD4030
MKBS3738V
MKBP3582V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Kamonpan Sanachai et al.
RSC medicinal chemistry, 12(3), 430-438 (2021-05-29)
The Janus kinase (JAK) and epidermal growth factor receptor (EGFR) have been considered as potential targets for cancer therapy due to their role in regulating proliferation and survival of cancer cells. In the present study, the aromatic alkyl-amino analogs of
Kamonpan Sanachai et al.
ACS omega, 7(37), 33548-33559 (2022-09-27)
Janus kinases (JAKs) are nonreceptor protein tyrosine kinases that play a role in a broad range of cell signaling. JAK2 and JAK3 have been involved in the pathogenesis of common lymphoid-derived diseases and leukemia cancer. Thus, inhibition of both JAK2
Kamonpan Sanachai et al.
ACS omega, 7(37), 33587-33598 (2022-09-27)
Janus kinases (JAKs) are involved in a wide variety of cell signaling associated with T-cell and B-cell mediated diseases. The pathogenesis of common lymphoid-derived diseases and leukemia cancer has been implicated in JAK2 and JAK3. Therefore, to decrease the risk
Kamonpan Sanachai et al.
ACS omega, 5(1), 369-377 (2020-01-21)
Janus kinases (JAKs) are enzymes involved in signaling pathways that affect hematopoiesis and immune cell functions. JAK1, JAK2, and JAK3 play different roles in numerous diseases of the immune system and have also been considered as potential targets for cancer
Chalita Washington et al.
PLoS genetics, 16(6), e1008715-e1008715 (2020-06-20)
Dysregulation of the Ras oncogene in development causes developmental disorders, "Rasopathies," whereas mutational activation or amplification of Ras in differentiated tissues causes cancer. Rabex-5 (also called RabGEF1) inhibits Ras by promoting Ras mono- and di-ubiquitination. We report here that Rabex-5-mediated

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service